TITLE 16 OCCUPATIONAL
AND PROFESSIONAL LICENSING
CHAPTER 2 ACUPUNCTURE
AND ORIENTAL MEDICINE PRACTITIONERS
PART 18 EDUCATIONAL
COURSES FOR EXPANDED PRACTICE CERTIFICATION
16.2.18.1 ISSUING
AGENCY: New Mexico Board of
Acupuncture and Oriental Medicine.
[16.2.18.1 NMAC - Rp,
16.2.18.1 NMAC, 6/16/2015]
16.2.18.2 SCOPE: All doctors of oriental medicine who are
certified for expanded practice or who are applicants for certification for
expanded practice, as well as all educational courses and applicants for
approval of educational courses.
[16.2.18.2 NMAC - Rp,
16.2.18.2 NMAC, 6/16/2015]
16.2.18.3 STATUTORY
AUTHORITY: This part is promulgated
pursuant to the Acupuncture and Oriental Medicine Practice Act, Section
61-14A-8.1. NMSA 1978.
[16.2.18.3 NMAC - Rp,
16.2.18.3 NMAC, 6/16/2015]
16.2.18.4 DURATION: Permanent.
[16.2.18.4 NMAC - Rp,
16.2.18.4 NMAC, 6/16/2015]
16.2.18.5 EFFECTIVE
DATE: June 16, 2015, unless a later
date is cited at the end of a section.
[16.2.18.5 NMAC - Rp,
16.2.18.5 NMAC, 6/16/2015]
16.2.18.6 OBJECTIVE:
Part 18 lists the prerequisites, educational course approval requirements, class
hours, curriculum knowledge and skills for certification in each of the four
following expanded practice categories: basic injection therapy, injection
therapy, intravenous therapy and bioidentical hormone therapy.
[16.2.18.6 NMAC - Rp,
16.2.18.6 NMAC, 6/16/2015]
16.2.18.7 DEFINITIONS: Refer to definitions in 16.2.1.7 NMAC.
[16.2.18.7 NMAC - N, 6/16/2015]
16.2.18.8 GENERAL
REQUIREMENTS FOR EDUCATIONAL COURSE APPROVAL: The board shall approve an educational course
for a specific category of expanded practice upon completion of the following
general requirements and the specific requirements listed for the specific
category of expanded practice educational course approval. All courses, with the
exception of basic injection therapy, shall adhere to ICE or NCCA
credentialing standards. All references
to application in this section refer to the educational course application.
A. The educational course shall provide at least the minimum number of hours of
education in the areas listed for the specific category of educational course
hours. One hour of education shall be
equal to that defined by the accreditation commission for acupuncture and
herbal medicine (ACAHM). The education
shall be in addition to the education required to meet the minimum educational
program requirements for licensure as a doctor of oriental medicine.
B. The educational course application
shall include a description of the education being provided as required by the
educational course general curriculum defined in
16.2.18.11 NMAC and the educational course curriculum defined for the specific
category of expanded practice for which the educational course is applying for
approval.
C. The educational course application
shall include the curriculum vitae for all teachers, and proposed substitute teachers all classes shall be taught by qualified teachers
approved by the board, provided the following conditions are met:
(1) the education in the pharmacology of
the authorized substances shall be taught by a licensed pharmacist, Pharm D or
a Ph.D. in pharmacology; and
(2) the education in the clinical
therapeutic use of the authorized substances shall be taught by a licensed
health care practitioner with appropriate training and a minimum of five years experience using the authorized substances.
D. The educational course application
shall include documentation that all required clinical practice hours shall
have a teacher to student ratio of at least one teacher to no more than eight
students.
E. The educational course application
shall include examples of the test questions that students enrolled in the
course are required to successfully pass in order to
ensure competence in all required areas. Testing methodology shall be approved by the
board and with the exception of basic injection
therapy, the testing shall be administered, subject to approval by a
credentialed PhD psychometrician, as described in the ICE or NCCA credentialing
standards and as approved by the board.
The educational course shall send all student
test scores and evaluation scores directly to the board.
F. The educational course application
shall include an example of the certificate that shall be given for successful
completion of the educational course.
G. Each educational course shall be
completed within two years of commencement of that course.
H. A student who is allergic or
hypersensitive to an authorized substance may be excused from participating in
clinical practice when such an authorized substance is being used.
I. A board member or an agent of the
board has the authority to observe, audit and evaluate
educational courses at any time after an application has been filed. A course audit or evaluation may result in
denial, suspension or revocation of the course’s approval by the board in
accordance with law.
J. The educational course provider
shall specify whether the organization offering the educational course is a
sole proprietorship, partnership, LLC, corporation or non-profit corporation
and shall provide proof of such legal business status.
K. An educational course shall submit a
new application on the form approved by the board, pay the appropriate fee
defined in 16.2.10 NMAC and comply with all other new application requirements
if any of the following changes:
(1) ownership;
(2) faculty; and
(3) curriculum.
L. An educational course shall inform
the board in writing, provided that the educational course certifies that all
factors defined in Subsection J of 16.2.18.8 NMAC remain unchanged, if any of
the following changes:
(1) name;
(2) address; and
(3) phone
number.
[16.2.18.8 NMAC - Rp,
16.2.18.7 NMAC, 6/16/2015; A, 4/25/2023; A, 10/22/2024]
16.2.18.9 EDUCATIONAL
COURSE APPROVAL BOARD REQUIREMENTS:
A. The board shall have final authority
for approval of all educational courses including classes and teachers.
B. The board shall notify the applicant
in writing by mail postmarked no more than 75 days after the receipt of the
initial application as to whether the application is complete or if not
complete, what documentation is needed to complete the application.
C. If the requested information is not
received at the board office within 75 days after notification
the board shall notify the applicant in writing by mail that the application
has expired.
D. Teaching must commence for an
approved course within six months of approval.
E. If
the application is expired or is denied, the applicant will have to reapply as
a new applicant.
[16.2.18.9 NMAC - Rp,
16.2.18.8 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.10 EDUCATIONAL
COURSE PREREQUISITES:
A. An applicant for an educational
course in expanded practice leading to certification must be a
NM licensed doctor of oriental medicine in good standing.
B. The basic injection course is a
prerequisite to injection therapy certification and intravenous therapy
certification.
C. Prior to enrolling in any expanded
practice educational course, the applicant shall submit proof of completion of
at least three college or university credit hours (30-45) contact hours in a
course in pharmacology from an accredited institution. A board approved on-line course is acceptable
or the applicant may sit for a pharmacology final exam at an accredited
institution to satisfy this requirement.
D. If applying for basic injection
therapy, injection therapy or intravenous therapy, the applicant shall submit
proof of completion of a four hour American heart association approved CPR or
basic life support (BLS) course; a current card that shall remain current until
the next July 31 annual renewal cycle will serve as proof.
[16.2.18.10 NMAC - Rp,
16.2.18.9 NMAC, 6/16/2015]
16.2.18.11 EDUCATIONAL COURSE GENERAL
CURRICULUM: Each educational course shall provide the
doctor of oriental medicine, who successfully completes the course, with the
following entry level general knowledge and skills, as well as the specific
knowledge and skills, at the current professional standard of care within the
context of an integrative healthcare system, defined for each specific category
of expanded practice education.
A. Expanded practice and prescriptive
authority and oriental medicine: knowledge of how the principles of the
developmental system of oriental medicine such as yin, yang, qi and xue apply to the expanded practice certifications.
B. Biomedical knowledge: anatomy,
physiology, pathology, endocrinology, biochemistry, pharmacology and diagnostic
options sufficient to provide a foundation required for the specific category
of expanded practice.
C. Pharmacology knowledge:
(1) of the biochemistry, pharmacology,
clinical application, safety and handling, side effects, interactions,
contraindications, safeguards and emergency procedures for all authorized
substances in the formulary defined for the relevant specific category of expanded
practice;
(2) of how to make a differential
diagnosis relative to the prescription or administration of authorized
substances in the formulary defined for the relevant specific category of
expanded practice;
(3) of the potency and appropriate dosage
of single and combined authorized substances in the formulary defined for the
relevant specific category of expanded practice;
(4) and skill in utilizing appropriate
clinic based aseptic technique; and
(5) of the compounding requirements of the
USP797 with regard to the authorized substances in the
formulary defined for the relevant specific category of expanded practice.
D. Referral:
(1) knowledge and understanding of the limits of their training, and skill and when it
is appropriate to refer; and
(2) knowledge of the options available
regarding referral including an understanding of the potential benefit or
contraindications of all categories of expanded practice.
E. Emergency care (previous CPR/BLS
certification):
(1) knowledge of how to recognize a
medical emergency situation arising in the clinic and
what emergency outcomes may arise relative to performing the authorized
diagnostic and therapeutic procedures and the prescription or administration of
the specifically authorized substances, what procedures and substances are best
for managing each emergency situation and whom to contact for emergency support
and care;
(2) skill in providing first aid and basic
life support until the medical emergency team arrives;
(3) appropriate initial screening for
potential allergic or adverse reactions;
(4) skill in identifying and responding to
adverse or allergic reactions or mild to severe; vasovagal reactions with
knowledge of appropriate support measures depending on the type of reaction:
(a) patient
reassurance;
(b) patient
positioning;
(c) oral OTC
diphenhydramine (benadryl) if appropriate;
(d) inhaled oxygen;
(e) inhaled OTC
epinephrine (primatine mist) or IM injected
epinephrine if appropriate; and
(f) emergency
ambulance transport;
(5) the immediate and longer term
indications of inadvertent pneumothorax and the appropriate procedure for
patient care and guidance in such situations.
F. Record keeping, storage and
dispensing of dangerous drugs and controlled substances and knowledge of:
(1) the proper storage requirements in the
clinic for the drugs, dangerous drugs and controlled substances in the
specifically authorized formulary;
(2) how to keep accurate records of all
authorized drugs, dangerous drugs and controlled substances obtained, stored,
compounded, administered or dispensed; and
(3) skill in handling and using
appropriate clean or aseptic technique for all drugs, dangerous drugs and
controlled substances in the specifically authorized formulary.
G. Pharmaceutical law knowledge of:
(1) the appropriate areas of New Mexico
pharmaceutical law;
(2) USP-797 that relates to compounding of
the authorized substances in the formulary defined for the relevant specific
category of expanded practice; and
(3) drugs, dangerous drugs, and controlled
substances and what dangerous drugs or controlled substances are or are not
authorized under the provisions of the specific category or categories of
expanded practice for which he is certified.
H. Scope of practice knowledge:
(1) of the areas of the New Mexico
Acupuncture and Oriental Medicine Practice Act and rules that are appropriate
to the scope of practice of a doctor or oriental medicine certified for the
specific category of expanded practice;
(2) understanding of what diagnostic or
therapeutic procedures are authorized by the specific category of expanded
practice; and
(3) understanding what substances in a
specific formulary are authorized for use by doctors of oriental medicine
certified for the specific category of expanded practice.
[16.2.18.11 NMAC - Rp,
16.2.18.10 NMAC, 6/16/2015]
16.2.18.12 BASIC
INJECTION THERAPY EDUCATIONAL COURSE APPROVAL: The board shall approve a basic injection
therapy educational course after the educational course provider submits to the
board:
A. a completed application;
B. the payment of the application fee
for expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation of having complied with
all educational course approval general requirements defined in 16.2.18.8 NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.11
NMAC;
E. documentation demonstrating that it
will provide the basic injection therapy educational course hours defined in
16.2.18.13 NMAC; and
F. documentation demonstrating that it
will provide the basic injection therapy educational course curriculum defined
in 16.2.18.14 NMAC; and
G. A passing grade of seventy percent is
required for certification to demonstrate learned knowledge.
[16.2.18.12 NMAC - Rp,
16.2.18.11 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.13 BASIC INJECTION THERAPY
EDUCATIONAL COURSE HOURS: The
education offered shall consist of a minimum total of 58 contact hours with at least the minimum number of
hours of education in the areas listed below:
A. eight hours in pharmacology and
biomedical differential diagnosis relative to the prescription, administration,
compounding and dispensing of the authorized substances in the basic injection
therapy formulary including homeopathic medicines;
B. two hours in the drawing and
compounding of the authorized substances intended for injection in compliance
with USP 797, utilizing approved aseptic technique and proper record keeping and, storage and dispensing of substances; at least half of
the required hours shall be clinical practice;
C. 14 hours in orthopedic and
neurological evaluation; at least half of these required hours shall be
clinical practice;
D. two hours in the theory and practice
of vapocoolant spray and stretch techniques using the
authorized vapocoolants; at least half of these
required hours shall be clinical practice;
E. 28 hours in the theory and practice
of injection therapy including: 11 hours of trigger point therapy and injection
of acupuncture points; 11 hours of basic mesotherapy; six hours of basic neural
therapy, and therapeutic injections (vitamins), using the authorized substances
in the basic injection therapy formulary; at least half of these required hours
shall be clinical practice;
F. one hour in pharmaceutical law as
provided by the New Mexico board of pharmacy;
G. one in oriental medicine scope of
practice relative to the authorized substances and techniques; and
H. a minimum of two hours in the use of
inhaled oxygen O2 and IM epinephrine for emergency use.
[16.2.18.13 NMAC - Rp,
16.2.18.12 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.14 BASIC INJECTION THERAPY
EDUCATIONAL COURSE CURRICULUM: The basic injection therapy educational
course curriculum shall provide the doctor of oriental medicine, who
successfully completes the course, with the educational course general
curriculum knowledge and skills defined in16.2.18.11 NMAC and the following
specific skills and knowledge of:
A. orthopedic and neurological physical
exam and differential diagnosis:
(1) anatomy regions to be examined and
treated;
(2) the most common orthopedic pain
differential diagnoses for these areas as well as other medical differential
diagnoses that should be ruled out;
(3) skill in interpreting physical exam
signs in context as evidence for or against the differential diagnoses;
(4) the most important treatment options
for these differential diagnoses including but not limited to injection
therapy, spray and stretch therapy, exercise, physical medicine, manipulation,
manual medicine, acupuncture, moxibustion, medical therapy with herbal
medicine, supplements, homeopathic medicines and diet therapy;
(5) which basic imaging methods, if any,
are useful in the examination of the above differential diagnoses; and
(6) and skill in selecting and performing
the most appropriate basic orthopedic and neurologic physical examination
methods including but not limited to the most basic forms of reflex testing,
motor power testing, sensory exam, common orthopedic provocations, ligament
stretch testing, accurate palpation and marking of anatomic landmarks, ligament
and tendon compression testing and myofascial trigger
point compression;
B. general injection therapy knowledge
of:
(1) the needles, syringes and other
equipment used to perform the various types of injection therapy;
(2) appropriate aseptic techniques and
clean needle procedures and techniques, and necessity of compliance with USP
797;
(3) the various solutions used in the
various styles of injection therapy and skill in properly drawing and
compounding into syringes the authorized substances intended for injection,
using approved aseptic technique; in compliance with USP 797;
(4) how to generate and carry out a
comprehensive treatment plan that addresses the causative factors leading to
pain and dysfunction from the perspective of the understanding of each style of
injection therapy, offers post treatment palliation and provides post therapy
recommendations to support rehabilitation and prevent recurrence;
(5) how to explain to the patient the
purpose of the therapy, the expected outcome and possible complications of the
therapy that could occur;
(6) understanding that injection therapy
techniques authorized for the basic injection therapy certification are limited
to intradermal, subcutaneous and intramuscular, injections; and
(7) the anatomical locations that are
relatively safe for injection therapy, as well as those locations that should
be avoided for injection therapy;
C. acupuncture point injection therapy
knowledge of:
(1) how acupuncture point injections can
complement traditional acupuncture;
(2) the conditions that can be treated
with acupuncture point injections; and
(3) skill in injecting acupuncture points;
D. trigger point therapy knowledge of:
(1) what a trigger point is, what the
causative factors leading to trigger points are, what the most common
perpetuating factors are and how to recognize and identify the most common pain
referral patterns in the head, back, hip and extremities;
(2) how to locate and palpate trigger
points; and
(3) skill in locating, injecting and
spraying and stretching the most commonly treated
trigger points and muscles;
E. neural therapy knowledge of:
(1) the relationship between interference
fields, the autonomic nervous system, pain and disease;
(2) skill in identifying common
interference fields in the body; and
(3) skill in injecting common neural
therapy injection sites such as peripheral nerves, scars, tonsils, intercutaneous and subcutaneous sites;
F. mesotherapy knowledge of:
(1) the mechanism of action of mesotherapy
injections for pain and sports medicine and cosmetic treatment; and
(2) skill in injecting using mesotherapy
methodology;
G. therapeutic injections knowledge of:
(1) how to evaluate the patient and
determine a treatment plan with appropriate dosage, using appropriate
authorized substances; and
(2) skill in performing therapeutic
injections at appropriate anatomical locations and depths.
[16.2.18.14 NMAC - Rp,
16.2.18.13 NMAC, 6/16/2015]
16.2.18.15 INJECTION THERAPY EDUCATIONAL COURSE
APPROVAL: The board shall approve an injection therapy
educational program requirements:
A. a completed application;
B. payment of the application fee for
expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation that it will comply
with all educational course approval general requirements defined in 16.2.18.8
NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.11
NMAC;
E. documentation demonstrating that it
will provide the injection therapy educational course hours defined in
16.2.18.17 NMAC;
F. documentation demonstrating that it
will provide the injection therapy educational course curriculum defined in
16.2.18.18 NMAC; and
G. documentation demonstrating that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician as described in the ICE credentialing standards. A passing grade of seventy percent is
required for certification to demonstrate learned knowledge.
[16.2.18.15 NMAC - Rp,
16.2.18.14 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.16 Injection
Therapy Course Prerequisites: only
a New Mexico licensed DOM, in good standing, and board certified in basic
injection therapy, may apply for an injection therapy educational course.
[16.2.18.16 NMAC - Rp,
16.2.18.15 NMAC, 6/16/2015]
16.2.18.17 INJECTION THERAPY EDUCATIONAL COURSE
HOURS: The
education shall be completed within two years of commencement of the
course as specified in Subsection G of 16.2.18.7 NMAC and consists of a minimum
total of 115 hours and with at least the minimum number of hours of education
in the areas listed below:
A. eight hours in pharmacology and
relevant pharmaceutical law, including compliance with USP 797 differential
diagnosis relative to the selection, prescription, compounding and
administration, of the authorized substances in the injection therapy formulary
listed in Paragraph (2) of Subsection F of 16.2.20.8 NMAC, and the use of some
of these substances as pain medicine: upon completion and certification in
injection therapy some of these substances can be used with previously learned
basic injection techniques including trigger point, mesotherapy, and neural
therapy techniques;
B. four hours in the art and practice of
phlebotomy in order to safely perform injection of
ozone or platelet rich plasma when considered as appropriate therapeutic
intervention and at least half of the required hours shall be in clinical
practice; a certificate of completion of a board approved course in phlebotomy
is acceptable;
C. 15 hours in a board approved course
in oxidative medicine;
D. 52 hours to include:
(1) the scientific principles of
prolotherapy;
(2) aseptic technique as it relates to
injecting a joint;
(3) detailed anatomy of joints, supporting
soft tissue structures, and specific injection sites;
(4) orthopedic and neurological functional
evaluation;
(5) the use of platelet rich plasma and prolozone;
(6) theory and practice of advanced neural
therapy techniques;
(7) differentiation and selection of
authorized substances in the injection therapy formulary as defined in
Paragraph (2) of Subsection F of 16.2.20.8 NMAC; and
(8) at least half of these required hours
shall be clinical practice;
E. 30 hours of diagnostic
musculoskeletal ultrasound and ultrasound guided musculoskeletal procedures
from a board approved course; and
F. six hours in the theory and practice
of advanced injection therapy techniques including: mesotherapy for cellulite
reduction, refer to Subsection F of 16.2.18.14 NMAC
and apitherapy: at least half of these hours shall be in clinical practice; a
certificate of completion from a board approved course in advanced mesotherapy
or apitherapy will be considered to meet these hours.
[16.2.18.17 NMAC - Rp,
16.2.18.16 NMAC, 6/16/2015]
16.2.18.18 INJECTION THERAPY EDUCATIONAL COURSE
CURRICULUM: The injection therapy educational course
curriculum shall provide the doctor of oriental medicine, who successfully
completes the course, with the educational course general curriculum knowledge
and skills defined in 16.2.18.11 and 16.2.18.14 NMAC and the following specific
knowledge and skills in:
A. regenerative injection therapy (RIT
or prolotherapy):
(1) understanding of the scientific
principles of prolotherapy, its application, alternatives, risks and
consequences;
(2) recognizing the most common pain
patterns generated from injured and lax ligaments of the joints of the
extremities, lumbar and sacral regions;
(3) the concept of tissue regeneration and
proliferation and how it can be promoted in the body;
(4) injecting some of the most commonly treated ligamentous, tendonous, and
cartilaginous and intra-articular structures of the joints of the extremities,
lumbar and sacral regions;
(5) how to perform regional anesthesia or
a nerve block for pain relief; and
(6) the use of diagnostic musculoskeletal
ultrasound and ultrasound guided procedures;
B. orthopedic and neurological physical
exam and differential diagnosis:
(1) anatomy of the regions to be examined
and treated;
(2) selecting and performing orthopedic
and neurologic physical examination methods including but not limited to reflex
testing, motor power testing, sensory exam, common orthopedic provocations,
ligament stretch testing, accurate palpation and marking of anatomic landmarks,
ligament and tendon compression testing;
(3) interpreting physical exam signs in
context as evidence for or against the differential diagnoses;
(4) most common orthopedic pain
differential diagnoses for these areas as well as other medical differential
diagnoses that should be ruled out; and
(5) the most important treatment options
for these differential diagnoses;
C. how to generate and carry out a
comprehensive treatment plan that addresses the causative factors leading to
pain and dysfunction from the perspective of the understanding of each style of
injection therapy, offers post treatment palliation and provides post therapy
recommendations to support rehabilitation and prevent recurrence:
(1) how to explain to the patient the
purpose of the therapy, the expected outcome and possible complications of the
therapy that could occur; and
(2) anatomical locations that are
relatively safe for injection therapy, as well as those locations that should
be avoided for injection therapy;
D. perform phlebotomy and collect and
centrifuge blood to be used for platelet rich plasma injection; knowledge of
diagnostic and physical exam findings which indicate the need for platelet rich
plasma as a treatment modality;
E. advanced neural therapy techniques;
knowledge and skills as described in 16.2.18.14 NMAC of basic injection;
F. advanced mesotherapy;
(1) how to evaluate and treat the patient
with cellulite including determination of a treatment plan, utilizing
appropriate substance(s) and dosing to accomplish treatment goals;
(2) how to evaluate and treat fat;
(3) technique of injections to reduce fat
or cellulite; and
(4) mechanisms of action of substances
used for cellulite and fat reduction;
G. apitherapy;
(1) knowledge of and skill in performing
apitherapy; and
(2) understanding theory and application
of apitherapy, expected outcomes, benefits and potential risks and
complications.
[16.2.18.18 NMAC - Rp,
16.2.18.17 NMAC, 6/16/2015]
16.2.18.19 INTRAVENOUS THERAPY EDUCATIONAL
COURSE APPROVAL REQUIREMENTS FOR CERTIFICATION: The board
will approve an intravenous therapy educational course for certification after
the educational course provider submits to the board:
A. a completed application;
B. the payment of the application fee
for expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation of having complied with
all educational course approval general requirements defined in 16.2.18.8 NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.10
NMAC;
E. documentation demonstrating that it
will provide the intravenous therapy educational course hours defined in
16.2.18.20 NMAC;
F. documentation demonstrating that it
will provide the intravenous therapy educational course curriculum defined in
16.2.18.21 NMAC; and
G. documentation that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician, as described in the ICE credentialing standards. A passing grade of seventy percent is required
for certification to demonstrate learned knowledge.
[16.2.18.19 NMAC - N,
6/16/2015; A, 10/22/2024]
16.2.18.20 INTRAVENOUS THERAPY COURSE
PREREQUISITES: Only a New Mexico licensed DOM, in good standing, and board certified
in basic injection therapy, may apply for an intravenous therapy educational
course in expanded practice.
A. Proof of current BLS/CPR certification
that will be current for two years from an American heart association, American
red cross, or American safety and health institute provider.
B. Proof of completion
of at least three semester hours of college level biochemistry from an
accredited institution that provides evaluation of competencies by
examination. A board approved college
level online course is acceptable.
[16.2.18.20 NMAC - N, 6/16/2015; A, 10/22/2024]
16.2.18.21 INTRAVENOUS THERAPY EDUCATIONAL
COURSE HOURS: The intravenous therapy educational coursework shall
be completed within two years of commencement of the course, Subsection G of 16.2.18.8
NMAC, and shall consist of a minimum of 137 total hours and with the minimum
number of hours of education in the areas listed below:
A. eight hours in the
pharmacology, biochemistry, relevant pharmaceutical law, including
16.19.36 NMAC, differential diagnosis and clinical application relative to the
selection, prescription, compounding and administration of the authorized
substances in the intravenous therapy formulary;
B. 10 hours in the studying, drawing and
sterile compounding, (in compliance with USP-797) of the authorized substances
intended for infusion and injection utilizing approved aseptic technique and
proper record keeping, and storage of substances. At least half of these
required hours shall be clinical practice;
C. 24 hours in all aspects of safely
performing phlebotomy, intravenous infusions and intravenous pushes including
calculation of osmolarity. At least half of these required hours shall be
clinical practice with documented evidence of having prepared and started at
least 10 IV’s. Proof of completion of a board approved phlebotomy course may be
applied toward a portion of these hours;
D. 24 hours in oxidative medicine as
defined in Paragraph (39) of Subsection B of 16.2.1.7 NMAC, including; ozone
therapy, ultraviolet blood irradiation (photoluminescence), hyperbaric oxygen
therapy and the use of oxygen therapeutically. At least half of these required
hours shall be in clinical practice;
E. 24 hours in nutritional IV’s; vitamin
C, meyers cocktails, vitamins, minerals, and amino
acids;
F. 24 hours in detoxification,
utilizing glutathione, phosphatidylcholine and calcium EDTA including practice
standards that meet the requirement guidelines from the College of Physician
and Surgeons of Alberta, on file in the board office;
G. 16 hours in blood chemistry analysis:
including instruction of normal value ranges, critical values, clinical
implications of abnormal values, and whether these values warrant
reconsideration of proceeding with any intravenous therapy;
H. five hours in urine analysis:
including evaluation of unprovoked and provoked nutrient and toxic element
testing;
I. one hour in pharmaceutical law as
provided by the New Mexico board of pharmacy; and
J. one hour in oriental medicine scope
of practice relative to the authorized substances and techniques.
[16.2.18.21 NMAC - N, 6/16/2015]
16.2.18.22 INTRAVENOUS THERAPY EDUCATIONAL
COURSE CURRICULUM: The intravenous therapy educational course curriculum
shall provide the doctor of oriental medicine, who successfully completes the
course, with the knowledge and skills defined in Section 10 of 16.2.18 NMAC and
the following specific knowledge and skills.
A. Pharmaceutical law: knowledge of
compatibility and sterile compounding procedures of authorized substances in
the intravenous therapy formulary in compliance with the compounding
requirements of the USP-797.
B. Diagnostic phlebotomy knowledge of:
(1) and skill in drawing blood for
diagnostic purposes using appropriate aseptic procedure;
(2) needles, lancets, winged sets,
syringes, vacutainer tubes, and other equipment used to draw blood for
diagnostic purposes; and
(3) the various blood tests most relevant
to the protocols being taught.
C. Intravenous therapy knowledge of:
(1) and skill in the use of the equipment
used for intravenous infusions;
(2) equipment used for an intravenous
push;
(3) equipment used for injecting a bolus
into an infusion;
(4) local anatomy of common infusion sites
and skill in selecting an appropriate infusion site;
(5) authorized substances that are
appropriate or not appropriate for intravenous infusion or injection from the
intravenous therapy formulary;
(6) concept and importance of osmolarity,
pH and skill in determining pH and calculating a given solution’s osmolarity
using an osmolarity chart simple
algebraic equation or computer software;
(7) prerequisite lab tests that should be
evaluated prior to initiating intravenous therapy of any kind;
(8) and skill in preparing and
administering an intravenous push, intravenous infusion and injecting a bolus
into an IV infusion; and
(9) possible complications that could
occur during an intravenous infusion or push and how to identify, treat and
manage these complications.
D. Oxidative medicine, photo-oxidation
and the use of oxygen therapeutically knowledge of:
(1) biochemistry of oxidative medicine
including the biological electron transfer sequence (BETS) oxidation and
reduction (redox) reactions;
(2) and skill in the relevant clinical
application and use of the authorized substances in the intravenous therapy
formulary;
(3) history, physics, equipment and
therapeutic use of ultraviolet blood irradiation (photoluminescence);
(4) history, physics, physiology and
therapeutic use, contraindications and safety considerations of hyperbaric
oxygen chamber therapy; and
(5) blood borne pathogen training.
E. Detoxification and chelation therapy
knowledge of:
(1) diagnostic tools available for
determining and tracking the therapeutic elimination of body
burden of toxic elements including hair analysis, blood analysis and urinalysis
with provocation agents;
(2) how to determine that the kidneys,
colon and liver are functioning appropriately prior to commencement of
detoxification or chelation diagnostic and therapeutic procedures;
(3) critical importance of, and methods
for, optimizing kidney and bowel function, and phase 1/phase 2 liver detox
pathways, prior to and during detoxification or chelation therapy, how to
recognize when these systems are overburdened and what to do if they are
overburdened;
(4) biochemistry, clinical use, and safety
concerns relevant to all modes of administration of the authorized substances
used in detoxification or chelation therapy; and
(5) how to explain to the patient the
purpose of the therapy, the expected outcome, alternatives and possible
complications of the therapy that could occur.
[16.2.18.22 NMAC- N, 6/16/2015]
16.2.18.23 INTRAVENOUS THERAPY EXPANDED PRACTICE CERTIFICATION: The board shall only issue certification to applicants after successful completion
of the intravenous therapy expanded practice course, and successful completion and documentation of a practicum to
include 150 hours under the supervision of a board approved physician and 300
individual patients to be completed within two years of completion of the
coursework.
[16.2.18.23 NMAC - N, 6/16/2015]
16.2.18.24 BIOIDENTICAL HORMONE THERAPY EDUCATIONAL
COURSE APPROVAL: The board shall
have final authority for approval of a bioidentical hormone educational program
upon completion of the following requirements. The educational course shall submit to the board:
A. a completed application;
B. payment of the application fee for
expanded practice educational course approval specified in 16.2.10 NMAC;
C. documentation that it will comply
with all educational course approval general requirements defined in 16.2.18.8
NMAC;
D. documentation demonstrating that it
will provide the educational course general curriculum defined in 16.2.18.11
NMAC;
E. documentation demonstrating that it
will provide the bioidentical hormone therapy educational course hours defined
in 16.2.18.25 NMAC;
F. documentation demonstrating that it
will provide the bioidentical hormone therapy educational course curriculum
defined in 16.2.18.26 NMAC; and
G. documentation demonstrating that
proposed test instruments have been reviewed and approved by a credentialed PhD
psychometrician, as described in the ICE credentialing standards. A passing grade of seventy percent is
required for certification to demonstrate learned knowledge.
[16.2.18.24 NMAC - Rp,
16.2.18.19 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.25 BIOIDENTICAL
HORMONE THERAPY EDUCATIONAL COURSE HOURS: The bioidentical hormone
educational course shall consist of a minimum total of 80 hours of education,
with at least 24 hours of practical experience defined in Subsections B, C, D,
E and F of 16.2.18.25 NMAC in the areas listed below:
A. eight hours in the pharmacology of
bioidentical hormones;
B. 18 hours in an overview of the
endocrine system, including the anatomy and interactive physiology of the
hypothalamic-pituitary-adrenal-thyroid (HPAT) and gonadal axis, the stress
response and normal adrenal and thyroid function; also
to include normal male and female sex hormone physiology; at least half of
these hours shall be in practice or review of case studies;
C. 20 hours in theory and practice of
endocrinology including evaluation and treatment of the patient with hormonal
dysfunction and imbalances including but not limited to; adrenal fatigue,
auto-immune endocrine disorders, hypothyroid, hyperthyroid, men’s hormone
imbalances and women’s hormonal imbalances pre, peri and post menopause and
consideration and assessment for treatment with bio-identical hormone
replacement therapy, BHRT; at least half of these hours will be in practice or
review of case studies;
D. 14 hours in blood chemistry analysis
including but not limited to; CBC, CMP, LFT, lipids, ferritin, homocysteine,
vitamin D, iodine, hs CRP, fibrinogen, ANA, ESR, HgBAIC, insulin antibodies;
E. two hours in urine analysis;
F. 16 hours in the assessment and
treatment of hormone and neurotransmitter imbalances through blood, urine and
saliva hormone testing and evaluation; appropriate treatment options for the
biomedical differential diagnoses including, but not limited to; adrenal
fatigue, thyroid imbalances, andropause, menopausal syndrome, and other male and
female hormone imbalances; at least half of these hours shall be in practice or
case study review;
G. one hour in pharmaceutical law as
provided by the New Mexico board of pharmacy; and
H. one hour in oriental medicine scope
of practice relative to the prescription or administration of the authorized
substances.
[16.2.18.25 NMAC - Rp,
16.2.18.20 NMAC, 6/16/2015; A, 10/22/2024]
16.2.18.26 BIOIDENTICAL HORMONE THERAPY
EDUCATIONAL COURSE CURRICULUM: The
bioidentical hormone therapy educational course curriculum shall provide the
doctor of oriental medicine, who successfully completes the course, with the
educational course general curriculum knowledge and skills defined in
16.2.18.11 NMAC and the following specific knowledge and skills:
A. bioidentical hormone therapy;
(1) anatomy, physiology, endocrinology,
pathology, biochemistry, pharmacology, diagnostic and referral options
including imaging, and clinical strategies with a focus on hormone pathways,
neurotransmitter imbalances, precursors and intermediaries relevant to
bioidentical hormone therapy;
(2) how to perform a diagnosis of the
various aspects of the endocrine and neurotransmitter system using blood,
urine, and saliva testing;
(3) the application, clinical use, dosage,
dosage adjustment or discontinuation consequences and safety concerns relevant
to all modes of administration of the authorized substances; and
(4) how to explain to the patient the
purpose, expected outcome, risks and possible complications of bioidentical
hormone therapy as well as the advantages of bioidentical hormone therapy,
relative to non bioidentical hormone therapy;
B. non-hormone therapy:
(1) how to optimize hormone balance using
authorized substances that are not hormones or are hormone precursors, and the
benefits and limits of such therapy; and
(2) how to explain to the patient the
purpose, expected outcome, risks and possible complications of non-hormone
therapy as well as the advantages of non-hormone therapy relative to
bioidentical hormone therapy.
[16.2.18.26 NMAC - Rp,
16.2.18.21 NMAC, 6/16/2015]
HISTORY OF 16.2.18 NMAC:
History of Repealed Material:
16.2.18 NMAC, Expanded
Practice Educational Courses, filed 1/9/2013, repealed, 6/16/2015.